KMG Psychiatry

Psychiatry

KMG Psychiatry is an integrative outpatient psychiatric practice operating under KAB Medical Group Inc, delivering mental health services to patients throughout San Diego, Chula Vista, and Vista, California. Since its founding in October 2016, the practice has focused on providing dependable, structured, accessible, and evidence-based outpatient psychiatric care. KMG Psychiatry was developed to meet the needs of individuals seeking consistent mental health support delivered through coordinated and individualized treatment.

History and Purpose of the Practice

KMG Psychiatry was established during a period when outpatient psychiatric services were often difficult to access. Many patients faced long delays in receiving an initial evaluation, limited follow-up availability, and fragmented care across providers. These barriers frequently disrupted treatment progress and contributed to worsening symptoms.

The practice was created to address these challenges directly. From the beginning, KMG Psychiatry emphasized timely scheduling, continuity of care, and comprehensive evaluations. This structure allowed providers to understand each patient’s clinical history better and to develop treatment plans that could be adjusted as progress was monitored over time.

Clinical Philosophy and Care Principles

The clinical philosophy at KMG Psychiatry is based on the understanding that psychiatric conditions are rarely straightforward. Mental health disorders often involve a combination of biological, psychological, and environmental factors. Because of this complexity, treatment is not limited to a single approach or short-term intervention.

Each patient begins care with a thorough psychiatric evaluation that includes symptom review, medical and psychiatric history, prior treatment response, and functional concerns. Providers use this information to develop individualized treatment plans. These plans are reviewed regularly and modified when needed, ensuring care remains responsive and clinically appropriate rather than fixed or formulaic.

Outpatient Services and Areas of Care

KMG Psychiatry provides outpatient psychiatric services for adults, adolescents, and children when clinically appropriate. The practice treats a wide range of psychiatric and neurodevelopmental conditions, including depressive disorders, anxiety disorders, bipolar disorder, post-traumatic stress disorder, autism spectrum disorders, and related diagnoses.

Services include psychiatric evaluations and medication management as core components of care. Psychotherapy and mental health counseling are offered to support emotional regulation, trauma processing, and behavioral change. The practice also provides forensic mental health services for individuals who require specialized psychiatric assessments. Sleep medicine services are incorporated when sleep disturbances contribute to psychiatric symptoms or interfere with recovery.

Focus on Depression and PTSD Treatment

A central area of focus at KMG Psychiatry is the treatment of depression and post-traumatic stress disorder. These conditions affect individuals across all age groups and backgrounds and are especially common among military personnel and underserved communities. The practice has developed experience in treating both emotional symptoms and functional limitations associated with these diagnoses.

KMG Psychiatry works with active-duty service members, veterans, and their families. Providers take into account occupational demands, deployment history, and lifestyle considerations when developing treatment plans. Care for military patients often combines medication management, psychotherapy, and interventional treatments when clinically indicated.

Role of Transcranial Magnetic Stimulation

Transcranial magnetic stimulation is a defining component of care at KMG Psychiatry. The practice uses NeuroStar Advanced Therapy, an FDA-cleared treatment approved for major depressive disorder since 2008. This technology delivers targeted magnetic pulses to specific regions of the brain involved in mood regulation.

TMS is often recommended for patients who have not experienced sufficient improvement with antidepressant medications or who have difficulty tolerating medication side effects. By directly stimulating underactive neural circuits, TMS provides an additional option within a broader and carefully managed treatment plan.

TMS Treatment Process and Patient Experience

At KMG Psychiatry, TMS treatments are delivered in an outpatient office setting. Patients remain awake and seated comfortably throughout each session. A magnetic coil is positioned against the scalp using a personalized mapping process completed before treatment begins.

During treatment sessions, patients may hear a clicking sound and feel a tapping sensation on the head. Each session typically lasts 19-37 minutes, depending on the individualized protocol. Treatments are scheduled five days per week over a four- to six-week period.

Many patients report improvements early in treatment, sometimes within the first week. This timeline differs from antidepressant medications, which often require several weeks to show benefit. Most patients complete a single course of TMS, although maintenance sessions may be offered when clinically appropriate.

Safety Profile and Side Effects

Transcranial magnetic stimulation is considered a noninvasive treatment with a favorable safety profile. It does not require anesthesia, surgery, or implanted devices. Cognitive function, memory, and sleep are not impaired, allowing patients to return to normal activities immediately after each session.

Common side effects include headaches, scalp discomfort, lightheadedness, facial muscle twitching, and tingling sensations. These effects are generally mild and temporary. Rare risks include seizures, hearing issues without adequate ear protection, and manic symptoms in individuals with bipolar disorder. Patients are carefully screened to ensure treatment is appropriate and risks are minimized.

Recognition and Professional Standing

KMG Psychiatry has received recognition for its clinical quality and community impact. The practice was voted Best in San Diego by SD Magazine in both 2024 and 2025, reflecting patient trust and regional acknowledgment.

At the national level, KMG Psychiatry holds Diamond Circle Provider status with NeuroStar. This designation is awarded to practices that administer more than 2,400 NeuroStar treatments annually. Achieving this status places KMG Psychiatry among the most experienced TMS providers in the United States and reflects its continued commitment to accessible, consistent, and evidence-based psychiatric care.